Unknown

Dataset Information

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?


ABSTRACT:

Introduction

Fifty years after the discovery of Δ9-tetrahydrocannabinol (THC) as the psychoactive component of Cannabis, we are assessing the possibility of translating this herb into clinical treatment of inflammatory bowel diseases (IBDs). Here, a discussion on the problems associated with a potential treatment is given. From first surveys and small clinical studies in patients with IBD we have learned that Cannabis is frequently used to alleviate diarrhea, abdominal pain, and loss of appetite. Single ingredients from Cannabis, such as THC and cannabidiol, commonly described as cannabinoids, are responsible for these effects. Synthetic cannabinoid receptor agonists are also termed cannabinoids, some of which, like dronabinol and nabilone, are already available with a n

SUBMITTER: Hasenoehrl C 

PROVIDER: S-EPMC5388177 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature